Reaction Biology
1 known investors
Reaction Biology is a contract research organization providing drug discovery and preclinical services, including enzyme and protein target profiling, cellular and phenotypic screening, bioanalytical testing, safety profiling, and immuno-oncology platforms. It serves pharmaceutical, biotech, and academic teams advancing compounds from early discovery through clinical development, operating across four sites in North America and Europe.
Investors Β· 1
Frequently asked questions
- What does Reaction Biology do?
- Reaction Biology is a contract research organization providing drug discovery and preclinical services, including enzyme and protein target profiling, cellular and phenotypic screening, bioanalytical testing, safety profiling, and immuno-oncology platforms. It serves pharmaceutical, biotech, and academic teams advancing compounds from early discovery through clinical development, operating across four sites in North America and Europe.
- Who are Reaction Biology's investors?
- Reaction Biology's investors include 1315 Capital.